The flu treatment Relenza looks unlikely to be made available on the National
Health Service in Britain. As Â鶹´«Ã½ went to press, the National
Institute for Clinical Excellence was thought to have advised against releasing
the drug, which limits symptoms and hastens recovery. Richard Sykes, chairman of
Glaxo Wellcome, the drug’s maker, is incensed. Yet a company data sheet prepared
in August states that the drug has yet to be shown to work in chronically ill or
immunocompromised patients, who are most at risk from complications of the
flu.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
We've found a mysterious substance on Titan and Pluto
2
Faecal transplant makes the brains of old mice act young again
3
Cervical cancer deaths have plummeted thanks to HPV vaccine
4
Most portable air conditioners suck – but there's an easy fix
5
The secrets to keeping your brain sharp in old age
6
Remarkable fossils rewrite the story of how animals conquered the land
7
Autism may have two distinct subtypes that vary by brain activity
8
Almost the whole of Japan moved eastward after 2011 earthquake
9
Can prebiotics, probiotics or postbiotics help your ageing microbiome?
10
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
